[The effect of cardioplegic solution on the function of the myocardial cell membrane].
Yoshida
K
K
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D002118:Calcium / Q000008:administration & dosage / Q000494:pharmacology; D002314:Cardioplegic Solutions / Q000494:pharmacology*; D002462:Cell Membrane / Q000187:drug effects / Q000502:physiology; D006168:Guinea Pigs; D066298:In Vitro Techniques; D007552:Isotonic Solutions / Q000494:pharmacology; D009206:Myocardium / Q000648:ultrastructure*; D010100:Oxygen / Q000494:pharmacology; D011188:Potassium / Q000008:administration & dosage / Q000494:pharmacology; D017680:Potassium Compounds; D012964:Sodium / Q000008:administration & dosage / Q000494:pharmacology
D002314:Cardioplegic Solutions; D007552:Isotonic Solutions; C051865:Krebs-Ringer solution; D017680:Potassium Compounds; C018369:potassium cardioplegic solution; D012964:Sodium; D011188:Potassium; D010100:Oxygen; D002118:Calcium